Vestibular dysfunction: Prevalence, impact and need for targeted treatment
Year: 2013
Type: article
Abstract: This manuscript is the first in a series on vestibular neuropharmacology, and serves to establish why it is important to develop pharmacologicinterventionsto treat disorders of the vestibular system. We will review the prevalence of vestibular disorders, present studies thatdescribetheimpactofvestibulardisordersonquality of life and clinically significant outcomes such as falls, and discuss the need for rational, targeted treatment. We will advance a central hypothesis, that for vestibular disorders with a well-defined pathophysiology, targeted, effective treatments exist. The prevalence of vestibular disorders has been estimated in several population-based studies, and can be categorized into studies that evaluated a cardinal symptom of vestibular dysfunction, vertigo; studies that estimated vestibular function using balance testing, and studies that considered the prevalence of specific vestibulardisorders.We will revieweach category of population-basedstudy in this order.A study in Germany queried a representative sample of the population about vestibular vertigo, which was defined as rotational vertigo (illusion of self-motion or object motion), positional vertigo (vertigo or dizziness precipitated by changes of head position, such as lying down or turning in bed) or recurrent dizziness with nausea and oscillopsia or imbalance. Neurotologic interviews
Source: Journal of Vestibular Research
DOI: 10.3233/ves-130498
Authors: Yuri Agrawal, Bryan K. Ward, Lloyd B. Minor
Institutions: Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funder: National Institute on Aging
OpenAlex ID: W1681684868
